PDCD1 and neoplasm: The currently recognized mechanism underlying the PD-1/PD-L1 axis blockade in tumour sites is that the interaction of PD-L1 on tumour cells with PD-1 on tumour-infiltrating T lymphocytes delivers negative signals and inhibits antitumor T cell response, facilitating tumorigenesis.